Abstract
Opioid receptors comprise a heterogeneous group that can be divided into at least four biochemically and topographically distinct subtypes, designated (μ, κ, σ, and δ. Martin et al. (1976) proposed the existence of μ-, κ-, and α-opioid receptors based on observed differences in pharmacological profiles of drugs seen with variably selective opioid agonists and antagonists. Other groups have provided evidence for the 8 subtype (Hughes et al., 1975).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Arguayo, L. G., Warnick, J. E., Maayani, S., Glick, S. D., Weinstein, H., and Alburquerque, E. X., 1982, Interaction of phencyclidine and its analogues on ionic channels of the electrically excitable membrane and nicotinic receptor: Implication for behavioral effects, Mol. Pharmacol. 21:637–647.
Alburquerque, E. X., Tsai, M. C., Aronstam, R., Witkop, B., Eldefrawi, A. R., and Eldefrawi, M. E., 1980, Phencyclidine interactions with the ionic channel of the acetylcholine receptor and electrogenic membrane, Proc. Natl. Acad. Sci. U.S.A. 77:1224–1228.
Bennett, H. P. J., Browne, C. A., Goltzman, D., and Solomon S., 1979, Isolation of peptide hormones by reverse-phase high pressure liquid chromatography, in: Peptides: Structure and Biological Function (E. Gross and J. Meienhofer, eds.), Pierce Chemical Co., Rockford, IL, pp. 121–125.
Brady, K. T., and Balster, R. L., 1981, Discriminative stimulus properties of phencyclidine and five analogues in the squirrel monkey, Pharmacol. Biochem. Behav. 14:213–218.
Brady, K. T., Balster, R. L., and May, E. L., 1982, Stereoisomers of N-allylnormetazocine: Phen-cyclidine-like behavioral effects in squirrel monkeys and rats, Science 215:178–179.
Chang, K. J., and Cuatrecasas, P., 1979, Novel opiate binding sites selective for benzomorphan drugs, J. Biol. Chem. 254:2610–2618.
Chang, K. J., and Cuatrecases, P., 1981, Heterogeneity and properties of opiate receptors, Fed. Proc. 40:2729–2734.
Chang, K. J., Cooper, B. R., Hazum, E., and Cuatrecasas, P., 1979, Multiple opiate receptors: Different regional distribution in the brain and differential binding of opiates and opioid peptides, Mol. Pharmacol. 16:91–104.
Contreras, P. C., Quirion, R., and O’Donohue, T. L., 1985a, Agonistic and antagonistic effects of PCP-derivatives and sigma opioids in PCP behavioral and receptor assays, NIDA Monogr. 64:80–94.
Contreras, P. C., Rafferty, M. F., Lessor, R. A., Rice, K. C., Jacobson, A. E., and O’Donohue, T. L., 1985b, A specific acylating ligand for phencyclidine (PCP) receptors antagonizes PCP behavioral effects, Fur. J. Pharmacol., 111:405–406.
Contreras, P. C., Rice, K. C., Jacobson, A. E., and O’Donohue, T. L., 1986a, Stereotyped behavior correlates better than ataxia with phencyclidine-receptor interactions Fur. J. Pharmacol. 121:9–
Contreras, P. C., Quirion, R., and O’Donohue, T. L., 1986b, Autoradiographic distribution of phencyclidine receptors in the rat brain using (3H)TCP Neurosci. Lett, (in press)
Domino, E. F., 1981, PCP: Historical and Current Perspectives, NPP Books, Ann Arbor.
Goldstein, A., Tachibana, S., Lowney, L. I., Hunkapiller, M., and Hood, L., 1979, Dynorphin-(1–13), an extraordinarily potent opioid peptide, Proc. Natl. Acad. Sci. U.S.A. 76:6666–66770.
Holtzman, S. G., 1980, Phencyclidine-like discriminative effects of opioids in the rat, J. Pharmacol. Exp. Ther. 214:614–620.
Hughes, J., 1975, Isolation of an endogenous compound from the brain with pharmacological properties similar to morphine, Brain Res. 88:295–308.
Hughes, J., Smith, T. W., Kosterlitz, H. W., Fotherfill, L. A., Morgen, B. A., and Morris, H. R., 1975, Identification of two related pentapeptides from the brain with potent opiate agonist activity, Nature 258:577–579.
Kosterlitz, H. W., and Paterson, S. J., 1980, Characterization of opioid receptors in nervous tissue, Proc. R. Soc. Lond. [Biol]. 210:113–126.
Largent, B. L., Gundlach, A. L., and Synder, S. H., 1984, Psychotomimetic opiate receptors labeled and visualized with (±)-(3H)3-(3-hydroxyphenyl)-N-(l-propyl)piperidine, Proc. Natl. Acad. Sci. U.S.A. 81:4983–4987.
Li, C. H., and Chung, D., 1976, Isolation and structure of an untriakontapeptide with opiate activity from camel pituitary glands, Proc. Natl. Acad. Sci. U.S.A. 73:1145–1148.
Lord, J., Waterfield, A., Hughes, J., and Kosterlitz, H., 1977, Endogenous opioid peptides: Multiple agonists and receptors, Nature 267:495–500.
Martin, B. R., Katzen, J. S., Woods, J. A., Tripathi, H. L., Harris, L. S., and May, E. L., 1984, Stereoisomers of (3H)-N-allylnormetazocine bind to different sites in mouse brain, J. Pharmacol. Exp. Ther. 231:539–544.
Martin, W. R., Eades, C. G., Thompson, J. A. Huppler, R. E., and Gilbert, P. E., 1976, The effects of morphine-and nalorphine-like drugs in the non-dependent and morphine-dependent chronic spinal dog, J. Pharmacol. Exp. Ther. 197:517–532.
O’Donohue, T. L., and Dorsa, D. M., 1982, The opiomelanotropinergic neuronal and endocrine sytems, Peptides 3:353–395.
O’Donohue, T. L., Pert, C. B., French, E., Pert, A., DiMaggio, D. A., Everist, H., and Quirion, R., 1983, Evidence for an endogenous CNS ligand for the PCP receptor, in: Peptides, Structure and Function (V. J. Hruby and D. H. Rich, eds.), Pierce Chemical Co., Rockford, IL, pp. 433–437.
Palkovits, M., Brownstein, M. J., and Zamir, N., 1983, Immunoreactive dynorphin and alpha-neo-endorphin in rat hypothalamo-neurohypophyseal system, Brain Res. 278:258–278.
Pilapil, C., Contreras, P. C., O’Donohue, T. L., and Quirion, R., 1985, Autoradiographic distribution of (3H)dexoxadrol, a phencyclidine-related ligand, binding sites in rat and human brain, Neurosci. Lett. 56:1–6.
Quirion, R., Rice, K. C., Skolnick, P., Paul, S., and Pert, C. B., 1981a, Stereospecific displacement of 3H phencyclidine (PCP) receptor binding by an enantiomeric pair of analogs, Eur. J. Pharmacol. 74:107–108.
Quirion, R., Hammer, R. P., Jr, Herkenham, M., and Pert, C. B., 1981b, Phencyclidine (angel dust)/sigma “opiate” receptor: Visualization by tritium-sensitive film, Proc. Natl. Acad. Sci. U.S.A 78:5881–5885.
Quirion, R., DiMaggio, D. A., French, E. D., Contreras, P. C., Shiloach, J., Pert, C. B., Everist, H., Pert, A., and O’Donohue, T. L., 1984, Evidence for an endogeous peptide ligand for the phencyclidine receptor, Peptides 15:967–973.
Rafferty, M. F., Mattson, M. Jacobson, A. E., and Rice, K. K, 1985, A specific acylating agent for the [3H]phencyclidine receptors in rat brain, FEBS Lett. 181:318–322.
Shannon, H. E., 1981, Evaluation of phencyclidine analogs on the basis of their discriminative stimulus properties in the rat, J. Pharmacol. Exp. Ther. 216:543–552.
Shannon, H. E., 1982, Pharmacological analysis of the phencyclidine-like discriminative stimulus properties of narcotic derivatives in rats, J. Pharmacol. Exp. Ther. 222:146–151.
Shannon, H. E., 1983, Pharmacological evaluation of N-allylnormetazocine (SKF-10,047) on the basis of its discriminative stimulus properties in rat, J. Pharmacol. Exp. Ther. 225:144–150.
Simantov, R., Childers, D., and Snyder, S., 1978, The opiate receptor binding interactions of 3H-methionine enkephalin, an opioid peptide, Eur. J. Pharmacol. 47:319–331.
Su, T. P., 1982, Evidence for sigma-opioid receptor: Binding of (3H)-SKF-10,047 to etorphine-inac-cessible sites in guinea pig brain, J. Pharmacol. Exp. Ther. 223:284–290.
Tarn, S. W., 1983, Naloxone-inaccessible sigma receptor in rat central nervous system, Proc. Natl. Acad. Sci. U.S.A. 80:6703–6707.
Teal, J. J., and Holtzman, S. G., 1980, Discriminative stimulus effects of cyclazocine in the rat, J. Pharmacol. Exp. Ther. 212:368–376.
Vaupel, D. B., McCoun, D., and Cone, E. J., 1984, Phencyclidine analogs and precursors: Rotarod and lethal dose studies in the mouse, J. Pharmacol. Exp. Ther. 230:20–27.
Vignon, J., Vincent, J. P., Bidard, J. N., Kamenka, J. M., Geneste, P., Monier, S., and Lazdunski, M., 1982, Biochemical properties of the brain phencyclidine receptor, Eur. J. Pharmacol. 81:531–542.
Vincent, J. P., Cavey, D., Kamenka, J. M., Geneste, P., and Lazdunski, M., 1978, Interaction of phencyclidine with the muscarinic and opiate receptors in the central nervous system, Brain Res. 152:176–182.
Vincent, J. P., Kartalovski, P., Geneste, J. M., and Lazdunski, M., 1979, Interaction of phencyclidine (“angel dust”) with a specific receptor in rat brain membranes, Proc. Natl. Acad. Sci. U.S.A. 76:4678–4682.
Zamir, N., Zamir, D., Eiden, L. E., Palkovits, M., Brownstein, M. J., Eskay, R. L., Weber, E., Faden, A. I., and Feuerstein, G., 1985, Methionine and leucine enkephalin in rat neurohypophysis: Different responses to osmotic stimuli and T2 toxin, Science 228:605–608.
Zukin, S. R., and Zukin, R. S., 1979, Specific 3H phencyclidine binding in rat central nervous system, Proc. Natl. Acad. Sci. U.S.A. 76:5372–5376.
Zukin, R. S., and Zukin, S. R., 1981, Demonstration of (3H)cyclazocine binding to multiple opiate receptor sites, Mol. Pharmacol. 20:246–254.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Plenum Press, New York
About this chapter
Cite this chapter
Contreras, P.C., Dimaggio, D.A., O’Donohue, T.L., Quirion, R. (1986). An Endogenous Peptide Ligand for the PCP/σ-Opiod Receptor. In: Moody, T.W. (eds) Neural and Endocrine Peptides and Receptors. GWUMC Department of Biochemistry Annual Spring Symposia. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5152-8_1
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5152-8_1
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-5154-2
Online ISBN: 978-1-4684-5152-8
eBook Packages: Springer Book Archive